Anna Sjögren

Technik-/Wissenschafts-/F&E-Leiter bei EGETIS THERAPEUTICS AB

56 Jahre

Health Technology

Consumer Services

Aktive Positionen von Anna Sjögren

Unternehmen	Position	Beginn	Ende
EGETIS THERAPEUTICS AB	Technik-/Wissenschafts-/F&E-Leiter	-	-

Unternehmen	Position	Beginn	Ende
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Corporate Officer/Principal	01.01.2013	01.12.2017

University of Uppsala	Undergraduate Degree
Karolinska Institutet	Undergraduate Degree

International

Schweden

Operativ

Undergraduate Degree	2
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Sektoral

Health Technology	3
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
EGETIS THERAPEUTICS AB	Health Technology

Private Unternehmen	1
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Health Technology

Private Unternehmen

Health Technology